Validation pour Ingenuity289

vers la météo de la validation par utilisateur

Ingenuity289

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 45 - PMID ?

In preadipocytes from SP exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of SP NODE mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                                                                               +-------COMP:N-N(of)-------+   
          +---------------------------------------COMP:V-N(In)--------------------------------------+          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+SUBJ:V-N+--------OBJ:V-N--------+                      +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |                      |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 1

                                                                                                               +-------COMP:N-N(of)-------+   
          +---------------------------------------COMP:V-N(In)--------------------------------------+          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +--------OBJ:V-N--------+                      +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |                      |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 2

          +---------------------------------------COMP:V-N(In)--------------------------------------+          +-------COMP:N-N(of)-------+   
          +--------SUBJ:V-N--------+                                                                |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +--------OBJ:V-N--------+                      +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |                      |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,preadipocytes)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 3

          +---------------------------------------COMP:V-N(In)--------------------------------------+          +-------COMP:N-N(of)-------+   
          |               +------------------------------COMP:V-N(from)-----------------------------+          |           +-MOD_ATT:N-ADJ+   
          |               +SUBJ:V-N+--------OBJ:V-N--------+                      +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |                      |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 4

          +---------------------------------------COMP:V-N(In)--------------------------------------+          +-------COMP:N-N(of)-------+   
          |               +------------------------------COMP:V-N(from)-----------------------------+          |           +-MOD_ATT:N-ADJ+   
          |               |        +--------OBJ:V-N--------+                      +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |                      |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 5

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +----------------------------SUBJ:V-N----------------------------+                                         
          |                        +-------------------------OBJ:V-N-------------------------+      |                                         
          |                        |                       +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |                       |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 6

          +---------------------------------------COMP:V-N(In)--------------------------------------+          +-------COMP:N-N(of)-------+   
          |                                                        +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+SUBJ:V-N+--------OBJ:V-N--------+       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 7

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +----------------------------SUBJ:V-N----------------------------+                                         
          |               |        +-------------------------OBJ:V-N-------------------------+      |                                         
          |               |        |                       +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |                       |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 8

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                                                |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+SUBJ:V-N+-OBJ:V-N+              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 9

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                                                |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+SUBJ:V-N+-----OBJ:V-N----+      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 10

          +---------------------------------------COMP:V-N(In)--------------------------------------+          +-------COMP:N-N(of)-------+   
          +--------SUBJ:V-N--------+                               +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +--------OBJ:V-N--------+       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,preadipocytes)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 11

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +--------SUBJ:V-N--------+                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +-OBJ:V-N+              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,preadipocytes)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 12

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +----------------------------SUBJ:V-N----------------------------+                                         
          |                        +-------------------------OBJ:V-N-------------------------+      |                                         
          |                        |                +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |                |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |                |      |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 13

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +--------SUBJ:V-N--------+                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +-----OBJ:V-N----+      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,preadipocytes)
OBJ:V-N (exhibit,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 14

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +----------------------------SUBJ:V-N----------------------------+                                         
          |                        +-------------------------OBJ:V-N-------------------------+      |                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |        |              |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 15

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +----------------------------SUBJ:V-N----------------------------+                                         
          |               |        +-------------------------OBJ:V-N-------------------------+      |                                         
          |               |        |                +---------------MOD_ATT:N-N--------------+      |                                         
          |               |        |                |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |                |      |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 16

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                         +---------------MOD_ATT:N-N--------------+      |                                         
          |                                         |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                                         |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+SUBJ:V-N+-OBJ:V-N+       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 17

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +----------------------------SUBJ:V-N----------------------------+                                         
          |               |        +-------------------------OBJ:V-N-------------------------+      |                                         
          |               |        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |               |        |        |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |        |              |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 18

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                         +---------------MOD_ATT:N-N--------------+      |                                         
          |                                         |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +--------SUBJ:V-N--------+                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        +-OBJ:V-N+       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
SUBJ:V-N (exhibit,preadipocytes)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 19

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+          +-------COMP:N-N(of)-------+   
          |               |                                        +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +SUBJ:V-N+--------OBJ:V-N--------+       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 20

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +----------------------------SUBJ:V-N----------------------------+                                         
          |                        +-------------------------OBJ:V-N-------------------------+      |                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |       +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |        |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |        |       |      |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 21

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |                                |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +SUBJ:V-N+-OBJ:V-N+              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 22

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +----------------------------SUBJ:V-N----------------------------+                                         
          |               |        +-------------------------OBJ:V-N-------------------------+      |                                         
          |               |        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |               |        |        |       +---------------MOD_ATT:N-N--------------+      |                                         
          |               |        |        |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |        |       |      |       |              +MOD_ATT:N-+      +--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
OBJ:V-N (exhibit,acid)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,exhibit)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 23

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |                                |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +SUBJ:V-N+-----OBJ:V-N----+      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 24

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |                         +---------------MOD_ATT:N-N--------------+      |                                         
          |               |                         |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |                         |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +SUBJ:V-N+-OBJ:V-N+       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 25

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |                        |                       +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |                       |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 26

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |                        |                +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |                |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |                |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 27

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |        |              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 28

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |               |        |                       +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |                       |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 29

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |       +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |        |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          +-COMP:N-N(from)+        |        |       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,__SP__)
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 30

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |               |        |                +---------------MOD_ATT:N-N--------------+      |                                         
          |               |        |                |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |                |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 31

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |               |        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |               |        |        |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |        |              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 32

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |               +------------------------------COMP:V-N(from)-----------------------------+                                         
          |               |        +-----------------------MOD_ATT:N-N-----------------------+      |                                         
          |               |        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |               |        |        |       +---------------MOD_ATT:N-N--------------+      |                                         
          |               |        |        |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |               |        |        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               |        |        |       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (acid,exhibit)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 33

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                                +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +-----COMP:N-N(from)-----+                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+                       |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,exhibit)
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 34

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                         +---------------MOD_ATT:N-N--------------+      |                                         
          |                                         |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +-----COMP:N-N(from)-----+                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+                |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,exhibit)
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 35

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                 +-------------------MOD_ATT:N-N------------------+      |                                         
          |                                 |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +-----COMP:N-N(from)-----+        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+        |              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,exhibit)
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 36

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-------------------------COMP:V-N(from)-------------------------+                                         
          |                        |                       +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                       |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+                       |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                       |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,exhibit)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 37

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                                 +-------------------MOD_ATT:N-N------------------+      |                                         
          |                                 |       +---------------MOD_ATT:N-N--------------+      |                                         
          |                                 |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          +-----COMP:N-N(from)-----+        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+        |       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (preadipocytes,exhibit)
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 38

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-------------------------COMP:V-N(from)-------------------------+                                         
          |                        |                +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |                |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |                |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+                |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |                |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,exhibit)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 39

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-------------------------COMP:V-N(from)-------------------------+                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |              +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |              |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+        |              |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |              |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,exhibit)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 40

          +---------------------------------------COMP:V-N(In)--------------------------------------+                                         
          |                        +-------------------------COMP:V-N(from)-------------------------+                                         
          |                        |        +-------------------MOD_ATT:N-N------------------+      |                                         
          |                        |        |       +---------------MOD_ATT:N-N--------------+      |                                         
          |                        |        |       |      +-----------MOD_ATT:N-N-----------+      |          +-------COMP:N-N(of)-------+   
          |                        |        |       |      |       +-------MOD_ATT:N-N-------+      |          |           +-MOD_ATT:N-ADJ+   
          |               +MOD_ATT:+        |       |      |       |              +MOD_ATT:N-+SUBJ:V+--OBJ:V-N-+           |       +MOD_AT+   
          |               |        |        |       |      |       |              |          |      |          |           |       |      |   
 In preadipocytes from __SP__ exhibiting Simpson Golabi Behmel syndrome , lysophosphatidic acid decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (exhibit,__SP__)
MOD_ATT:N-N (acid,Simpson)
MOD_ATT:N-N (acid,Golabi)
MOD_ATT:N-N (acid,Behmel)
MOD_ATT:N-N (acid,syndrome)
MOD_ATT:N-ADJ (acid,lysophosphatidic)
COMP:V-N(In) (decrease,preadipocytes)
COMP:V-N(from) (decrease,exhibit)
SUBJ:V-N (decrease,acid)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)